SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-24-136215
Filing Date
2024-05-10
Accepted
2024-05-10 16:30:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFR14A d822757ddefr14a.htm DEFR14A 18169
  Complete submission text file 0001193125-24-136215.txt   19246
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-36548 | Film No.: 24935451
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)